Biomathematical Approaches to Cancer
癌症的生物数学方法
基本信息
- 批准号:6915181
- 负责人:
- 金额:$ 21.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-03-01 至 2007-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Clones of intermediate cells on the pathway to cancer, such as adenomatous polyps and altered hepatic foci, are often observed in humans and animals. These lesions provide insights into the earliest stages of the carcinogenic process. Because clonal expansion of cells that are partially transformed can increase the probability of cancer substantially, a quantitative understanding of these lesions is key to understanding cancer rates. The broad objective of this project is to continue the development of mathematical, statistical and computational tools, within the paradigm of multistage carcinogenesis, for the quantitative analyses of early lesions on the pathway to malignancy. The fundamental goals of these analyses are to study the temporal evolution of these lesions, to estimate the rate of initiation of the lesions, and the rates of cell division and apoptosis of the partially transformed cells that comprise the lesion. Information on such early lesions is typically available from initiation-promotion experiments, particularly in the rodent liver.In previous work mathematical expressions have been developed for the number and size distribution of intermediate lesions on the pathway to malignancy and used for analyses of initiation-promotion experiments in rat liver. This proposal plans to extend this work in light of new biological information. In addition to continuing work on analyses of liver foci in rodents, the research proposed here will investigate intermediate lesions in the human colon and in patients with Barrett's esophagus, a high-risk precursor condition for adenocarcinoma of the esophagus. In addition to the mathematical and statistical problems associated with clonal growth models within the paradigm of multistage carcinogenesis, both analyses of liver foci and analyses of lesions in Barrett's esophagus present diverse problems. Recognizing that modeling is an iterative process an integral part of this effort will be collaboration with experimentalists and human biologists, in particular Dr. Michael Schwarz, University of Tubingen, an expert on the rodent liver system, Dr. John Potter, an epidemiologist with expertise on colon cancer and Dr. Brian Reid, Director of the Seattle Barrett's Esophagus Project. The results of analyses will be used to help generate biologically relevant questions and hypotheses and to plan further experiments and studies, which, in turn, will lead to more refined models.
描述(申请人提供):在人类和动物中经常观察到致癌途径上的中间细胞的克隆,例如腺瘤性息肉和改变的肝脏病灶。这些病变提供了对致癌过程的早期阶段的洞察。由于部分转化的细胞的克隆性扩张会显著增加癌症的可能性,因此对这些损伤的定量了解是了解癌症发生率的关键。该项目的广泛目标是在多阶段癌症发生的范例内继续开发数学、统计和计算工具,用于对癌变途径上的早期病变进行定量分析。这些分析的基本目标是研究这些病变的时间演变,估计病变的起始率,以及构成病变的部分转化细胞的细胞分裂和凋亡率。关于这种早期病变的信息通常可以从启动促进实验中获得,特别是在啮齿类动物的肝脏中。在以前的工作中,已经建立了致癌途径上中间病变的数量和大小分布的数学表达式,并用于分析大鼠肝脏的启动促进实验。这项提案计划根据新的生物信息延长这项工作。除了继续对啮齿类动物的肝脏病灶进行分析外,这里提出的研究还将调查人类结肠和Barrett‘s食道患者的中间病变,Barrett’s食道是食管腺癌的高风险前驱疾病。除了与多阶段癌变范式中的克隆生长模型相关的数学和统计学问题外,对肝脏病灶的分析和对Barrett‘s食道病变的分析都存在各种问题。认识到建模是一个迭代过程,这项工作的一个组成部分将是与实验者和人类生物学家合作,特别是图宾根大学啮齿动物肝脏系统专家迈克尔·施瓦茨博士、结肠癌专业流行病学家约翰·波特博士和西雅图巴雷特食道项目主任布莱恩·里德博士。分析的结果将被用来帮助产生与生物学相关的问题和假说,并计划进一步的实验和研究,这反过来将导致更精确的模型。
项目成果
期刊论文数量(26)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Biologically based analysis of the data for the Colorado uranium miners cohort: Age, dose and dose-rate effects
- DOI:10.2307/3580219
- 发表时间:1999-10-01
- 期刊:
- 影响因子:3.4
- 作者:Luebeck, EG;Heidenreich, WF;Moolgavkar, SH
- 通讯作者:Moolgavkar, SH
Quantitative analysis of enzyme-altered foci in rat hepatocarcinogenesis experiments--I. Single agent regimen.
大鼠肝癌实验中酶改变灶的定量分析--I.
- DOI:10.1093/carcin/11.8.1271
- 发表时间:1990
- 期刊:
- 影响因子:4.7
- 作者:Moolgavkar,SH;Luebeck,EG;deGunst,M;Port,RE;Schwarz,M
- 通讯作者:Schwarz,M
A method for parametric estimation of the number and size distribution of cell clusters from observations in a section plane
- DOI:10.2307/2533999
- 发表时间:1998-03-01
- 期刊:
- 影响因子:1.9
- 作者:de Gunst, MCM;Luebeck, EG
- 通讯作者:Luebeck, EG
Quantitative analysis of enzyme-altered liver foci in rats initiated with diethylnitrosamine and promoted with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin.
用二乙基亚硝胺启动并用 2,3,7,8-四氯二苯并-对二恶英或 1,2,3,4,6,7,8-七氯二苯并-对二恶英促进的大鼠酶改变肝脏病灶的定量分析。
- DOI:10.1006/taap.1996.0094
- 发表时间:1996
- 期刊:
- 影响因子:3.8
- 作者:Moolgavkar,SH;Luebeck,EG;Buchmann,A;Bock,KW
- 通讯作者:Bock,KW
Exploring heterogeneity in tumour data using Markov chain Monte Carlo.
使用马尔可夫链蒙特卡罗探索肿瘤数据的异质性。
- DOI:10.1002/sim.1441
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:deGunst,MathiscaCM;Dewanji,Anup;Luebeck,EGeorg
- 通讯作者:Luebeck,EGeorg
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SURESH H MOOLGAVKAR其他文献
SURESH H MOOLGAVKAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SURESH H MOOLGAVKAR', 18)}}的其他基金
Lung Cancer in the US: Pathogenesis, Trends, Prevention
美国肺癌:发病机制、趋势、预防
- 批准号:
6545083 - 财政年份:2002
- 资助金额:
$ 21.63万 - 项目类别:
Stochastic models for radiation carcinogenesis: tempora*
辐射致癌的随机模型:tempora*
- 批准号:
6592904 - 财政年份:2002
- 资助金额:
$ 21.63万 - 项目类别:
Lung Cancer in the US: Pathogenesis, Trends, Prevention
美国肺癌:发病机制、趋势、预防
- 批准号:
6799971 - 财政年份:2002
- 资助金额:
$ 21.63万 - 项目类别:
Lung Cancer in the US: Pathogenesis, Trends, Prevention
美国肺癌:发病机制、趋势、预防
- 批准号:
6950039 - 财政年份:2002
- 资助金额:
$ 21.63万 - 项目类别:
Lung Cancer in the US: Pathogenesis, Trends, Prevention
美国肺癌:发病机制、趋势、预防
- 批准号:
6656866 - 财政年份:2002
- 资助金额:
$ 21.63万 - 项目类别:
Stochastic models for radiation carcinogenesis: tempora*
辐射致癌的随机模型:tempora*
- 批准号:
6751851 - 财政年份:2002
- 资助金额:
$ 21.63万 - 项目类别:
相似国自然基金
RGD-68Ga@AuNCs PET监测PRMT5通过VEGFA调节肺腺癌血管新生的功能及机制
- 批准号:82372007
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
- 批准号:30840003
- 批准年份:2008
- 资助金额:12.0 万元
- 项目类别:专项基金项目
相似海外基金
Project 1: Overcoming therapeutic resistance in pancreatic cancer through epigenetic reprogramming
项目1:通过表观遗传重编程克服胰腺癌的治疗耐药性
- 批准号:
10629063 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别:
Defining cell intrinsic and extrinsic regulators of ferroptosis in pancreatic cancer
定义胰腺癌铁死亡的细胞内在和外在调节因子
- 批准号:
10679812 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别:
Neuroendocrine differentiation post anti-androgenic therapy: Role of Tribbles 2
抗雄激素治疗后的神经内分泌分化:Tribbles 2 的作用
- 批准号:
10659525 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别:
Combination of tumor targeted therapy with stroma modulating agent for PDAC
肿瘤靶向治疗与基质调节剂联合治疗 PDAC
- 批准号:
10629924 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别:
BCCMA: Overcoming chemoresistance in ovarian cancer: Identification and validation of biomarkers and targetable drivers of platinum resistance
BCCMA:克服卵巢癌的化疗耐药性:铂类耐药的生物标志物和靶向驱动因素的识别和验证
- 批准号:
10585641 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别:
Enteric Glia is New Biological Target to Block Drug Resistance in Colon Cancer
肠胶质细胞是阻断结肠癌耐药性的新生物靶点
- 批准号:
10659846 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别:
Investigating CD4+ T cell memory in cancer immunotherapy
研究癌症免疫治疗中的 CD4 T 细胞记忆
- 批准号:
10739583 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别: